Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Angelastro

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Mitochondrion|October 27, 2019
Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancerSonia A Allen, Sandipan Datta, Jose Sandoval, et al.
Molecular and Cellular Neurosciences|June 14, 2005
ATF5 regulates the proliferation and differentiation of oligodendrocytesJeffrey L Mason, James M Angelastro, Tatyana N Ignatova, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2003
Regulated expression of ATF5 is required for the progression of neural progenitor cells to neuronsJames M Angelastro, Tatyana N Ignatova, Valery G Kukekov, et al.
Cancers|June 2, 2021
Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer AgentsQing Zhou, Xiotian Sun, Nicolas Pasquier, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 15, 2005
Downregulation of activating transcription factor 5 is required for differentiation of neural progenitor cells into astrocytesJames M Angelastro, Jeffrey L Mason, Tatyana N Ignatova, et al.
Cancer Letters|June 19, 2023
A complex of Wnt/planar cell polarity signaling components Vangl1 and Fzd7 drives glioblastoma multiforme malignant propertiesCourtney A Dreyer, Kacey VanderVorst, Dean Natwick, et al.
Pharmaceuticals (Basel, Switzerland)|December 1, 2020
Novel mTORC1 Inhibitors Kill Glioblastoma Stem CellsJose A Sandoval, Alexey Tomilov, Sandipan Datta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2016
A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant CancersGeorg Karpel-Massler, Basil A Horst, Chang Shu, et al.
Cancer Research Communications|November 28, 2023
Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis ResistanceDebarshi Banerjee, Shuobo Boboila, Shunpei Okochi, et al.
Human Molecular Genetics|October 12, 2010
Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical developmentChristopher L Cunningham, Verónica Martínez Cerdeño, Eliecer Navarro Porras, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Mitochondrion|October 27, 2019
Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancerSonia A Allen, Sandipan Datta, Jose Sandoval, et al.
Molecular and Cellular Neurosciences|June 14, 2005
ATF5 regulates the proliferation and differentiation of oligodendrocytesJeffrey L Mason, James M Angelastro, Tatyana N Ignatova, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2003
Regulated expression of ATF5 is required for the progression of neural progenitor cells to neuronsJames M Angelastro, Tatyana N Ignatova, Valery G Kukekov, et al.
Cancers|June 2, 2021
Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer AgentsQing Zhou, Xiotian Sun, Nicolas Pasquier, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 15, 2005
Downregulation of activating transcription factor 5 is required for differentiation of neural progenitor cells into astrocytesJames M Angelastro, Jeffrey L Mason, Tatyana N Ignatova, et al.
Cancer Letters|June 19, 2023
A complex of Wnt/planar cell polarity signaling components Vangl1 and Fzd7 drives glioblastoma multiforme malignant propertiesCourtney A Dreyer, Kacey VanderVorst, Dean Natwick, et al.
Pharmaceuticals (Basel, Switzerland)|December 1, 2020
Novel mTORC1 Inhibitors Kill Glioblastoma Stem CellsJose A Sandoval, Alexey Tomilov, Sandipan Datta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2016
A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant CancersGeorg Karpel-Massler, Basil A Horst, Chang Shu, et al.
Cancer Research Communications|November 28, 2023
Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis ResistanceDebarshi Banerjee, Shuobo Boboila, Shunpei Okochi, et al.
Human Molecular Genetics|October 12, 2010
Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical developmentChristopher L Cunningham, Verónica Martínez Cerdeño, Eliecer Navarro Porras, et al.
Pageof 4